SK6842002A3 - Modified peptides and peptidomimetics for use in immunotherapy - Google Patents

Modified peptides and peptidomimetics for use in immunotherapy Download PDF

Info

Publication number
SK6842002A3
SK6842002A3 SK684-2002A SK6842002A SK6842002A3 SK 6842002 A3 SK6842002 A3 SK 6842002A3 SK 6842002 A SK6842002 A SK 6842002A SK 6842002 A3 SK6842002 A3 SK 6842002A3
Authority
SK
Slovakia
Prior art keywords
ser
gly
thr
ala
phe
Prior art date
Application number
SK684-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Staveren Catherina Joanna Van
Cornelis Marius Timmers
Van Phillippus Johannes Galen
Rnaldus Marcellus Alph Knegtel
Anna Maria Helena Boots
Andreas Martinus Ma Miltenburg
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of SK6842002A3 publication Critical patent/SK6842002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
SK684-2002A 1999-10-18 2000-10-12 Modified peptides and peptidomimetics for use in immunotherapy SK6842002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99203427 1999-10-18
PCT/EP2000/010230 WO2001029081A1 (en) 1999-10-18 2000-10-12 Modified peptides and peptidomimetics for use in immunotherapy

Publications (1)

Publication Number Publication Date
SK6842002A3 true SK6842002A3 (en) 2002-09-10

Family

ID=8240756

Family Applications (1)

Application Number Title Priority Date Filing Date
SK684-2002A SK6842002A3 (en) 1999-10-18 2000-10-12 Modified peptides and peptidomimetics for use in immunotherapy

Country Status (23)

Country Link
EP (1) EP1226167A1 (pt)
JP (1) JP2003512388A (pt)
KR (1) KR20020047245A (pt)
CN (1) CN1379786A (pt)
AR (1) AR026068A1 (pt)
AU (1) AU780238B2 (pt)
BR (1) BR0014803A (pt)
CA (1) CA2386398A1 (pt)
CO (1) CO5271650A1 (pt)
CZ (1) CZ20021356A3 (pt)
HK (1) HK1046693A1 (pt)
HU (1) HUP0203504A3 (pt)
IL (1) IL148778A0 (pt)
MX (1) MXPA02003520A (pt)
NO (1) NO20021763D0 (pt)
NZ (1) NZ518256A (pt)
PE (1) PE20010692A1 (pt)
PL (1) PL354590A1 (pt)
RU (1) RU2002113107A (pt)
SK (1) SK6842002A3 (pt)
TR (1) TR200201036T2 (pt)
WO (1) WO2001029081A1 (pt)
ZA (1) ZA200202577B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002951212A0 (en) * 2002-09-04 2002-09-19 Monash University A method of modulating cellular activity and molecules for use therein
US20100240137A1 (en) * 2006-04-06 2010-09-23 Purdue Research Foundation Derivatization-enhanced analysis of amino acids and peptides
EP2114462B1 (en) * 2006-12-21 2013-06-05 Universite De Geneve Compounds for fluorescence imaging
AU2009207922B2 (en) 2008-01-23 2015-05-14 Herlev Hospital YKL-40 as a general marker for non-specific disease
NZ592241A (en) 2008-09-15 2012-11-30 Herlev Hospital Ykl-40 as a marker for gastrointestinal cancers
EP3215172B1 (en) * 2014-11-07 2023-04-26 Kineta Chronic Pain, Llc. Modifications and uses of conotoxin peptides
EP3466963A1 (en) * 2017-10-05 2019-04-10 Suigeneris Farmacosmetics, S.L. Anticancer peptides and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
IL120561A0 (en) * 1996-04-24 1997-07-13 Akzo Nobel Nv Peptides suitable for use in immunosuppressive therapy
WO1997046578A1 (en) * 1996-06-07 1997-12-11 Zeneca Limited Peptide derivatives
IL122233A (en) * 1996-12-06 2001-04-30 Akzo Nobel Nv Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them

Also Published As

Publication number Publication date
RU2002113107A (ru) 2004-01-10
CN1379786A (zh) 2002-11-13
EP1226167A1 (en) 2002-07-31
WO2001029081A1 (en) 2001-04-26
CO5271650A1 (es) 2003-04-30
HUP0203504A2 (hu) 2003-04-28
ZA200202577B (en) 2003-09-23
HK1046693A1 (zh) 2003-01-24
NZ518256A (en) 2004-01-30
CA2386398A1 (en) 2001-04-26
NO20021763L (no) 2002-04-15
AR026068A1 (es) 2002-12-26
IL148778A0 (en) 2002-09-12
MXPA02003520A (es) 2002-08-20
HUP0203504A3 (en) 2005-03-29
CZ20021356A3 (cs) 2002-07-17
JP2003512388A (ja) 2003-04-02
PE20010692A1 (es) 2001-07-06
TR200201036T2 (tr) 2002-08-21
BR0014803A (pt) 2002-06-11
AU780238B2 (en) 2005-03-10
NO20021763D0 (no) 2002-04-15
KR20020047245A (ko) 2002-06-21
AU1139601A (en) 2001-04-30
PL354590A1 (en) 2004-01-26

Similar Documents

Publication Publication Date Title
AU704502B2 (en) Non-dendritic backbone peptide carrier
EP1896498B1 (en) Epitope analogues
IE912701A1 (en) Novel immunosuppressant peptides
Hervé et al. On the immunogenic properties of retro-inverso peptides. Total retro-inversion of T-cell epitopes causes a loss of binding to MHC II molecules
SK166798A3 (en) Peptide derivatives, process for their preparation, pharmaceutical composition them containing, and their use
US6821517B1 (en) Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
WO1986004334A1 (en) Immunoregulatory peptides
US20070161545A1 (en) Triple polypeptide complexes
JP3468528B2 (ja) ペプチド誘導体
JPS63502106A (ja) 抗原とｔ４リンパ球との相互作用を阻害し得るペプチド及び該ペプチドから誘導された産生物及びそれらの使用
US7122193B1 (en) Retro peptides, antibodies thereto and their uses for vaccination and in vitro diagnosis
US6465614B1 (en) High-affinity response-selective C-terminal analogs of C5a anaphylatoxin
JPH10501791A (ja) クラスｉｍｈｃペプチドによる細胞傷害性ｔ細胞リンパ球（「ｃｔｌ」）活性の調節
SK6842002A3 (en) Modified peptides and peptidomimetics for use in immunotherapy
US6436903B1 (en) Immunomodulating compounds comprising d-isomers of amino acids
US6683048B1 (en) Compounds and methods for stimulating gene expression and cellular differentiation
Maillère et al. Fine chemical modifications at N-and C-termini enhance peptide presentation to T cells, by increasing the lifespan of both free and MHC-complexed peptides
RU2502741C2 (ru) Пептиды со способностью связываться со скурфином и их применение
Saito et al. Contribution of peptide backbone atoms to binding of an antigenic peptide to class I major histocompatibility complex molecule
AU2002339227A1 (en) Triple polypeptide complexes
BR112019020148A2 (pt) peptídeo
CA2182486C (en) Cyclic neurokinin a antagonists
JPH11507620A (ja) 合成ペプチドおよびそれらを含有する医薬組成物
Skarlas et al. HLA‐DQ7 β1 and β2 derived peptides as immunomodulators
JP2001511143A (ja) コラーゲン▲ｉｉ▼に特異的なｔ細胞エピトープを含むペプチド

Legal Events

Date Code Title Description
FC9A Refused patent application